Chemical modification of human albumin at cys34 by ethacrynic acid: structural characterisation and binding properties

Journal of Pharmaceutical and Biomedical Analysis

Volumn 18, Issue 1-2, 1998, Pages 127-136

  Bertucci, Carlo ^a   Nanni, Barbara ^a   Raffaelli, Andrea ^a   Salvadori, Piero ^a  

^a CNR   (Italy)

Author keywords

Circular dichroism; Cys34 modified HAS; Ethacrynic acid; Mass spectrometry; Protein binding

Indexed keywords

BILIRUBIN; CYSTEINE; DIAZEPAM; ETACRYNIC ACID; HUMAN ALBUMIN; PHENYLBUTAZONE;

ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; COVALENT BOND; DRUG PROTEIN BINDING; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL;

ALBUMINS; BILIRUBIN; BINDING SITES; CIRCULAR DICHROISM; CYSTEINE; DIAZEPAM; ELECTROPHORESIS; ETHACRYNIC ACID; HUMANS; MASS SPECTROMETRY; MOLECULAR STRUCTURE; PHENYLBUTAZONE; PROTEIN BINDING;

EID: 0031768811     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(98)00163-0     Document Type: Article

References (45)

1. Muller W.E., Wollert U. Pharmacology. 19:1979;59-67.
2. Peters T.Jr. Serum albumin. Adv. Protein Chem. 37:1985;161-245.
3. Kragh-Hansen U. Pharmacol. Rev. 33:1981;17-53.
4. Fehske K.J., Mueller W.E., Wollert U. Biochem. Pharmacol. 30:1981;687-692.
5. He X.M., Carter D.C. Nature. 358:1992;209-215.
6. Carter D.C., Ho J.X. Adv. Protein Chem. 45:1994;153-203.
7. Harding J.J. Adv. Protein Chem. 37:1985;247-334.
8. Kragh-Hansen U. Dan. Med. Bull. 37:1990;54-87.
9. Day J.F., Thorpe S.R., Baynes J.W. J. Biol. Chem. 254:1979;595-597.
10. Dolhofer R., Wieland O.H. FEBS Lett. 103:1979;282-286.
11. Gunthrow C.E., Morris M.A., Day J.F., Thorpe S.R., Baynes J.W. Proc. Natl. Acad. Sci. 76:1979;4258-4261.
12. Garlick R.L., Mater J.S. J. Biol. Chem. 258:1983;6142-6146.
13. Baynes J.W., Thorpe S.R., Murtiashaw M.H. Methods Enzymol. 106:1984;88-98.
14. Shaklai N., Garlick R.L., Bunn H.F. J. Biol. Chem. 256:1984;3812-3817.
15. Okabe N., Hashizume N. Biol. Pharm. Bull. 17:1994;16-21.
16. Farr R.S., Rodnan G.P., Lasser E.C. J. Clin. Invest. 40:1961;1037-1039.
17. Farr R.S., Reid R.T., Minden P. J. Clin. Invest. 45:1966;1006-1012.
18. Farr R.S. J. Allergy. 45:1970;321-331.
19. Walker J.E. FEBS Lett. 66:1976;173-175.
20. Bertucci C., Viegi A., Ascoli G., Salvadori P. Chirality. 7:1995;57-61.
21. Stamler J.S., Jaraki O., Osborne J., Simon D.I., Keaney J., Vita J., Singel D., Valeri R., Loscalzo J. Proc. Natl. Acad. Sci. USA. 89(16):1992;7674-7677.
22. Shaw C.F., Isab A.A., Hoeschele J.D., Starich M., Locke J., Schulteis P., Xiao J. J. Am. Chem. Soc. 116:1994;2254-2260.
23. Vorum H., Fisker K., Otagiri M., Pedersen A.O., Kragh-Hansen U. Clin. Chem. 41(11):1995;1654-1661.
24. Christodoulou J., Sadler P.J. FEBS Lett. 376:1995;1-5.
25. Era S. Acta Sch. Med. Univ. Gifu. 39:1991;6-24.
26. Era S., Kuwata K., Imai H., Nakamura K., Hayashi T., Sogami M. Biochim. Biophys. Acta. 1247:1995;12-16.
27. Van Der Vliet A., Cross C.E., Halliwell B., O'Neill C.A. Methods Enzymol. (Biothiols Part A). 251:1995;448-455.
28. Narazaki R., Hamada M., Harada K., Otagiri M. Pharm. Res. 13:1996;1317-1321.
29. Bertucci C., Wainer I.W. Chirality. 9:1997;335-340.
30. Fehske K.J., Müller W.E. Pharmacology. 32:1986;208-213.
31. Takamura N., Haruta A., Kodama H., Tsuruoka M., Yamasaki K., Suenaga A., Otagiri M. Pharm. Res. 13(7):1996;1015-1019.
32. Sellers E.M., Koch-Weser J. Clin. Pharmacol. Ther. 11:1970;524-529.
33. Yvon M., Anglade P., Wal J.M. Fed. Eur. Biochem. Soc. 263(2):1990;237-240.
34. Magi B., Marzocchi B., Bini L., Cellesi C., Rossolini A., Pallini V. Electrophoresis. 16:1995;1190-1192.
35. Park B., Kitteringham N. Drug Metab. Rev. 22:1990;87-144.
36. Chen R.F. J. Biol. Chem. 242:1967;173-181.
37. Elwell M.L., Shellman J.A. Biochim. Biophys. Acta. 494:1977;367-383.
38. Koechel D.A., Smith S.A., Cafruny E.J. J. Pharm. Exp. Ther. 203(2):1977;272-282.
39. Ascoli G., Bertucci C., Salvadori P. J. Pharm. Sci. 84:1995;137-141.
40. Benesi H.A., Hildebrand J.H. J. Am. Chem. Soc. 71:1949;2703-2707.
41. Greenfield N., Fasman J.D. Biochem. 8:1969;4108-4116.
42. Rosen A. Biochem. Pharmacol. 19:1970;2075-2081.
43. Perrin J.H., Nelson D.A. J. Pharm. Pharmacol. 25:1973;125-130.
44. Roodsorp N., Sjokolm I. Biochem. Pharmacol. 25:1976;2141-2145.
45. C. Bertucci, P. Salvadori, E. Domenici, in: Hassan, Y. Aboul-Enein, I.W. Wainer (Eds.), The Impact of Stereochemistry on Drug Development and Use, Wiley, New York, 1997, pp. 521-543.